Biopharma Canada
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany


Achieving Success with Strong Partnerships

EMD Serono, Canada, is focused on specialty markets for prescription pharmaceuticals. Seasoned professionals both at an executive as well as a sales level ensure our future success. In addition, a highly dedicated, in-house patient services team makes certain we listen to our customers and provide the support patients need.
We welcome collaborative or licensing opportunities with institutions or companies, with a focus on neurodegenerative diseases, oncology, and autoimmune as well as inflammatory diseases. We will consider compounds in late stage development as well as already existing brands, which meet most of the criteria outlined below.

Therapeutic area

  • Neurodegenerative Diseases
  • Oncology
  • Autoimmune and inflammatory diseases

Preferred product / technology characteristics

  • Innovative
  • Addresses a significant unmet medical need
  • Significant market size potential
  • Marketing rights available
  • Chemistry, manufacturing and controls in reasonable order
  • Strong intellectual property protection

Advantages of EMD Serono as licensing partner

  • Market leadership in multiple sclerosis and fertility
  • Leading role in international clinical studies and Canadian-based research
  • Innovative patient support systems
  • Surpassing average industry review and approval time through Health Canada
  • Experienced sales force across Canada


If you are interested in working with us, please fill out the form below and submit it online.